Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lon protease homolog, mitochondrial (LONP1) is a highly conserved, nuclear-encoded ATP-dependent serine protease located within the mitochondrial matrix. As a member of the AAA+ (ATPases Associated with diverse cellular Activities) superfamily, it plays a critical role in mitochondrial protein quality control by selectively degrading misfolded, unassembled, or oxidatively damaged proteins, such as aconitase and TFAM. Beyond its proteolytic function, LONP1 acts as a molecular chaperone to facilitate the folding and assembly of mitochondrial protein complexes and binds to mitochondrial DNA (mtDNA) to regulate its maintenance and transcription. In the context of disease, LONP1 is frequently overexpressed in various cancers, where it supports cell survival under hypoxic and oxidative stress conditions, making it a promising therapeutic target. Conversely, loss-of-function mutations in LONP1 are the primary cause of CODAS syndrome, a rare multisystem developmental disorder. Small molecule inhibitors, such as the synthetic triterpenoid CDDO and its derivative CDDO-Me (Bardoxolone methyl), have been shown to directly inhibit LONP1, leading to the accumulation of mitochondrial protein aggregates and the induction of apoptosis in cancer cells.
Inhibition of the proteolytic activity or the ATPase activity of LONP1, which prevents the degradation of damaged proteins and leads to the accumulation of mitochondrial protein aggregates, ultimately triggering apoptosis in cancer cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lon protease homolog, mitochondrial (LONP1).